In support of this notion, it was recently shown that GBM-infiltrating T cells increased their expression of indoleamine 2,3-dioxygenase 1 (IDO1), which is an immune-inhibitory receptor and that this heightened expression correlates with poor prognosis (26). Here, IDO1 is linked to glioblastoma.